News
-
-
REGULATED PRESS RELEASE
bioMérieux – 2024 Financial Results
-
-
-
REGULATED PRESS RELEASE
bioMérieux launches GENE-UP® TYPER, an innovative diagnostic solution for food industries to rapidly analyze the root cause of contamination of Listeria monocytogenes
bioMérieux launches GENE-UP® TYPER, an innovative real-time PCR solution for rapid root cause analysis in food industries, targeting Listeria monocytogenes contamination -
-
REGULATED PRESS RELEASE
bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid
bioMérieux receives U.S. FDA clearance for the new version of its molecular test, the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid, targeting causes of gastroenteritis. The test detects 11 common bacteria, viruses, and parasites from one sample in about 1 hour, improving patient outcomes -
-
-
